These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12904303)

  • 1. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.
    Fiorani P; Bruselles A; Falconi M; Chillemi G; Desideri A; Benedetti P
    J Biol Chem; 2003 Oct; 278(44):43268-75. PubMed ID: 12904303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
    Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
    Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.
    Tesauro C; Morozzo della Rocca B; Ottaviani A; Coletta A; Zuccaro L; Arnò B; D'Annessa I; Fiorani P; Desideri A
    Mol Cancer; 2013 Sep; 12(1):100. PubMed ID: 24004603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.
    van der Merwe M; Bjornsti MA
    J Biol Chem; 2008 Feb; 283(6):3305-3315. PubMed ID: 18056711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation.
    Wang Z; D'Annessa I; Tesauro C; Croce S; Ottaviani A; Fiorani P; Desideri A
    Biochim Biophys Acta; 2015 Aug; 1854(8):860-8. PubMed ID: 25910424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.
    D'Annessa I; Tesauro C; Wang Z; Arnò B; Zuccaro L; Fiorani P; Desideri A
    Biochim Biophys Acta; 2013 Dec; 1834(12):2712-21. PubMed ID: 24096022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality.
    Losasso C; Cretaio E; Palle K; Pattarello L; Bjornsti MA; Benedetti P
    J Biol Chem; 2007 Mar; 282(13):9855-9864. PubMed ID: 17276985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.
    Gromova II; Kjeldsen E; Svejstrup JQ; Alsner J; Christiansen K; Westergaard O
    Nucleic Acids Res; 1993 Feb; 21(3):593-600. PubMed ID: 8382801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance.
    Wang Z; D'Annessa I; Tesauro C; Ottaviani A; Soren BC; Dasari JB; Messina B; Thareparambil A; Fiorani P
    Arch Biochem Biophys; 2019 Mar; 663():165-172. PubMed ID: 30653963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.
    Arnò B; D'Annessa I; Tesauro C; Zuccaro L; Ottaviani A; Knudsen B; Fiorani P; Desideri A
    PLoS One; 2013; 8(7):e68404. PubMed ID: 23844196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1999 Nov; 274(46):32950-60. PubMed ID: 10551862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.
    Colley WC; van der Merwe M; Vance JR; Burgin AB; Bjornsti MA
    J Biol Chem; 2004 Dec; 279(52):54069-78. PubMed ID: 15489506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate.
    Fertala J; Vance JR; Pourquier P; Pommier Y; Bjornsti MA
    J Biol Chem; 2000 May; 275(20):15246-53. PubMed ID: 10809761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.
    Svejstrup JQ; Christiansen K; Gromova II; Andersen AH; Westergaard O
    J Mol Biol; 1991 Dec; 222(3):669-78. PubMed ID: 1660929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study.
    Chillemi G; Fiorani P; Castelli S; Bruselles A; Benedetti P; Desideri A
    Nucleic Acids Res; 2005; 33(10):3339-50. PubMed ID: 15944452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
    Knab AM; Fertala J; Bjornsti MA
    J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domains of human topoisomerase I and associated functions.
    Champoux JJ
    Prog Nucleic Acid Res Mol Biol; 1998; 60():111-32. PubMed ID: 9594573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lysine 532 in the catalytic mechanism of human topoisomerase I.
    Interthal H; Quigley PM; Hol WG; Champoux JJ
    J Biol Chem; 2004 Jan; 279(4):2984-92. PubMed ID: 14594810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
    Benedetti P; Fiorani P; Capuani L; Wang JC
    Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CPT on the DNA cleavage/religation reaction mediated by calf thymus Topoisomerase I: evidence of an inhibition of DNA religation. Inhibition of Topoisomerase I-mediated DNA religation by CPT.
    Carboni MC; Coderoni S
    Mol Biol Rep; 1994-1995; 20(3):129-33. PubMed ID: 7565652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.